Our mission is to significantly reduce amputations and mortality globally due to infected chronic wounds. 

The skin represents the essence of every human identity and any damage to it has severe repercussions on the individual’s quality of life. It still remains a great challenge to effectively, rapidly and with high quality, repair chronic wounds such as diabetic foot ulcers, pressure ulcers and venous leg ulcers due to infection. In the UK alone, the annual cost of managing chronic wounds that fail to heal is estimated to be £3.2 billion. Unfortunately, the incidence of chronic wounds is increasing with the rise in the ageing population and the levels of obesity/diabetes. 629 million people worldwide are estimated to have diabetes by 2045.

Our business solution is an innovative polymeric dressing that can detect and treat chronic infection in an easy clinical setting.